Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Jakko Van Ingen; Stefano Aliberti; Claire Andrejak; James D. Chalmers; Luigi R. Codecasa; Charles L. Daley; Naoki Hasegawa; David E. Griffith; Wouter Hoefsloot; Gwen Huitt; Julie Jarand; Byung Woo Jhun; Michael R. Loebinger; Theodore K. Marras; Kozo Morimoto; Eva Polverino; Felix C. Ringshausen; Miguel Santin; Rachel Thomson; Dirk Wagner; Richard J. Wallace; Kevin L. Winthrop; Jae Joon Yim

doi:10.1093/cid/ciaa1361

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Jakko Van Ingen, Stefano Aliberti, Claire Andrejak, James D. Chalmers, Luigi R. Codecasa, Charles L. Daley, Naoki Hasegawa, David E. Griffith, Wouter Hoefsloot, Gwen Huitt, Julie Jarand, Byung Woo Jhun, Michael R. Loebinger, Theodore K. Marras, Kozo Morimoto, Eva Polverino, Felix C. Ringshausen, Miguel Santin, Rachel Thomson, Dirk WagnerRichard J. Wallace, Kevin L. Winthrop, Jae Joon Yim

Department of Infectious Diseases

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

Original language	English
Pages (from-to)	E256-E259
Journal	Clinical Infectious Diseases
Volume	73
Issue number	1
DOIs	https://doi.org/10.1093/cid/ciaa1361
Publication status	Published - 2021 Jul 1

Keywords

Mycobacterium avium complex
adverse events
antibiotic treatment
azithromycin
nontuberculous mycobacteria

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciaa1361

Cite this

Van Ingen, J., Aliberti, S., Andrejak, C., Chalmers, J. D., Codecasa, L. R., Daley, C. L., Hasegawa, N., Griffith, D. E., Hoefsloot, W., Huitt, G., Jarand, J., Jhun, B. W., Loebinger, M. R., Marras, T. K., Morimoto, K., Polverino, E., Ringshausen, F. C., Santin, M., Thomson, R., ... Yim, J. J. (2021). Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey. Clinical Infectious Diseases, 73(1), E256-E259. https://doi.org/10.1093/cid/ciaa1361

Van Ingen, J, Aliberti, S, Andrejak, C, Chalmers, JD, Codecasa, LR, Daley, CL, Hasegawa, N, Griffith, DE, Hoefsloot, W, Huitt, G, Jarand, J, Jhun, BW, Loebinger, MR, Marras, TK, Morimoto, K, Polverino, E, Ringshausen, FC, Santin, M, Thomson, R, Wagner, D, Wallace, RJ, Winthrop, KL & Yim, JJ 2021, 'Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey', Clinical Infectious Diseases, vol. 73, no. 1, pp. E256-E259. https://doi.org/10.1093/cid/ciaa1361

@article{5ee82787cf7e452a8849470e19be8859,

title = "Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey",

abstract = "Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.",

keywords = "Mycobacterium avium complex, adverse events, antibiotic treatment, azithromycin, nontuberculous mycobacteria",

author = "{Van Ingen}, Jakko and Stefano Aliberti and Claire Andrejak and Chalmers, {James D.} and Codecasa, {Luigi R.} and Daley, {Charles L.} and Naoki Hasegawa and Griffith, {David E.} and Wouter Hoefsloot and Gwen Huitt and Julie Jarand and Jhun, {Byung Woo} and Loebinger, {Michael R.} and Marras, {Theodore K.} and Kozo Morimoto and Eva Polverino and Ringshausen, {Felix C.} and Miguel Santin and Rachel Thomson and Dirk Wagner and Wallace, {Richard J.} and Winthrop, {Kevin L.} and Yim, {Jae Joon}",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.",

year = "2021",

month = jul,

day = "1",

doi = "10.1093/cid/ciaa1361",

language = "English",

volume = "73",

pages = "E256--E259",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease

T2 - An Expert Panel Survey

AU - Van Ingen, Jakko

AU - Aliberti, Stefano

AU - Andrejak, Claire

AU - Chalmers, James D.

AU - Codecasa, Luigi R.

AU - Daley, Charles L.

AU - Hasegawa, Naoki

AU - Griffith, David E.

AU - Hoefsloot, Wouter

AU - Huitt, Gwen

AU - Jarand, Julie

AU - Jhun, Byung Woo

AU - Loebinger, Michael R.

AU - Marras, Theodore K.

AU - Morimoto, Kozo

AU - Polverino, Eva

AU - Ringshausen, Felix C.

AU - Santin, Miguel

AU - Thomson, Rachel

AU - Wagner, Dirk

AU - Wallace, Richard J.

AU - Winthrop, Kevin L.

AU - Yim, Jae Joon

PY - 2021/7/1

Y1 - 2021/7/1

N2 - Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

AB - Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

KW - Mycobacterium avium complex

KW - adverse events

KW - antibiotic treatment

KW - azithromycin

KW - nontuberculous mycobacteria

UR - http://www.scopus.com/inward/record.url?scp=85111789608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111789608&partnerID=8YFLogxK

U2 - 10.1093/cid/ciaa1361

DO - 10.1093/cid/ciaa1361

M3 - Article

C2 - 32910814

AN - SCOPUS:85111789608

SN - 1058-4838

VL - 73

SP - E256-E259

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 1

ER -

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this